A Scoping Review of Varying Mobile Electrocardiographic Devices

Abstract

The electrocardiogram (ECG) can now be measured using mobile devices. Mobile ECG devices, which are defined as devices capable of recording and transmitting non-standard ECGs, offer numerous advantages such as cost-effectiveness and being user-friendly. Mobile ECG can also extend recording lengths (e.g., 2 days, 14 days), which is necessary to capture important intermittent events (e.g., cardiac arrhythmias) and evaluate prognostic risk markers (e.g., prolonged corrected QT (QTc) interval). Some mobile ECG devices can even connect to broadband networks allowing patients to remotely transmit their ECG to a clinician. This article systematically examines different mobile ECG devices used in prior studies and provides a detailed assessment of five diverse yet commonly used mobile ECG devices: AliveCor KardiaMobile; AliveCor KardiaMobile 6L; iRhythm ZioPatch; Apple Smartwatch ECG; and CardioSecur System. These mobile ECG devices are diverse in the number of leads measured and the duration of monitoring. Similar to their diversity, there has been a wide range of clinical applications of mobile ECG devices. Despite significant progress, questions regarding data quality, and clinican and patient acceptance and compliance persist.

Evaluating the use of the mobile electrocardiogram technology KardiaMobile™ in community settings: An online survey

“…There are numerous commercially available wearable and handheld mobile ECG devices directly marketed to consumers for AF monitoring and identification of unknown AF (Dzikowicz, 2024 ). KardiaMobile™ is one such example that has been introduced in clinical practice and is the only device that has Medical Technologies Guidance (MTG) published by the National Institute for Health and Care Excellence (NICE, 2022 ).…”